Status: Not yet recruiting
JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure
The goal of this clinical trial is to evaluate the safety and efficacy of JDB153 combined with Serplulimab in patients with pancreatic cancer after standard treatment failure.
Participants needed: 10
Trial details
Phase: Phase 1, Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: West China HospitalUpdated: Sep 16, 2025Locations: 1
Eligibility criteria
1) Histologically or cytologically confirmed diagnosis of locally advanced, unre...
1) History of other malignant tumors with disease-free survival <5 years (except...